Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Nutrients ; 14(2)2022 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-35057457

RESUMEN

Osteoporosis is a major health concern in aging populations, where 54% of the U.S. population aged 50 and older have low bone mineral density (BMD). Increases in inflammation and oxidative stress play a major role in the development of osteoporosis. Men are at a greater risk of mortality due to osteoporosis-related fractures. Our earlier findings in rodent male and female models of osteoporosis, as well as postmenopausal women strongly suggest the efficacy of prunes (dried plum) in reducing inflammation and preventing/reversing bone loss. The objective of this study was to examine the effects of two doses of prunes, daily, on biomarkers of inflammation and bone metabolism in men with some degree of bone loss (BMD; t-score between -0.1 and -2.5 SD), for three months. Thirty-five men between the ages of 55 and 80 years were randomized into one of three groups: 100 g prunes, 50 g prunes, or control. Consumption of 100 g prunes led to a significant decrease in serum osteocalcin (p < 0.001). Consumption of 50 g prunes led to significant decreases in serum osteoprotegerin (OPG) (p = 0.003) and serum osteocalcin (p = 0.040), and an increase in the OPG:RANKL ratio (p = 0.041). Regular consumption of either 100 g or 50 g prunes for three months may positively affect bone turnover.


Asunto(s)
Densidad Ósea/fisiología , Huesos/metabolismo , Osteoporosis/sangre , Fitoterapia/métodos , Prunus domestica , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Composición Corporal , Remodelación Ósea , Ejercicio Físico , Humanos , Inflamación/sangre , Inflamación/prevención & control , Vértebras Lumbares/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Osteocalcina/sangre , Osteoporosis/prevención & control , Fracturas Osteoporóticas/prevención & control , Osteoprotegerina/sangre , Ligando RANK/sangre
2.
Nutrients ; 12(10)2020 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-33007863

RESUMEN

Over 200 million people suffer from osteoporosis worldwide. Individuals with osteoporosis have increased rates of bone resorption while simultaneously having impaired osteogenesis. Most current treatments for osteoporosis focus on anti-resorptive methods to prevent further bone loss. However, it is important to identify safe and cost-efficient treatments that not only inhibit bone resorption, but also stimulate anabolic mechanisms to upregulate osteogenesis. Recent data suggest that macrophage polarization may contribute to osteoblast differentiation and increased osteogenesis as well as bone mineralization. Macrophages exist in two major polarization states, classically activated macrophages (M1) and alternatively activated macrophage (M2) macrophages. The polarization state of macrophages is dependent on molecules in the microenvironment including several cytokines and chemokines. Mechanistically, M2 macrophages secrete osteogenic factors that stimulate the differentiation and activation of pre-osteoblastic cells, such as mesenchymal stem cells (MSC's), and subsequently increase bone mineralization. In this review, we cover the mechanisms by which M2 macrophages contribute to osteogenesis and postulate the hypothesis that regulating macrophage polarization states may be a potential treatment for the treatment of osteoporosis.


Asunto(s)
Calcificación Fisiológica/fisiología , Polaridad Celular/fisiología , Activación de Macrófagos/fisiología , Macrófagos/fisiología , Osteoporosis/fisiopatología , Animales , Proteína Morfogenética Ósea 2/metabolismo , Diferenciación Celular , Humanos , Interleucina-4/metabolismo , Osteoblastos/fisiología , Osteogénesis/fisiología , Osteoporosis/tratamiento farmacológico , Factor de Necrosis Tumoral alfa/metabolismo
3.
Nutrients ; 12(7)2020 Jul 08.
Artículo en Inglés | MEDLINE | ID: mdl-32650580

RESUMEN

Type 2 diabetes (T2D) is a major contributor to morbidity and mortality largely due to increased cardiovascular disease risk. This study examined the relationships among protein consumption and sources on glycemic control and cardiovascular health in individuals with prediabetes and T2D. Sixty-two overweight or obese participants with prediabetes or T2D, aged 45-75 years were stratified into the following three groups based on protein intake: <0.8 g (gram)/kg (kilogram) body weight (bw), ≥0.8 but <1.0 g/kg bw, and ≥1.0 g/kg bw as below, meeting, and above the recommended levels of protein intake, respectively. Body mass, body mass index (BMI), hip circumference (HC), waist circumference (WC), lean mass, and fat mass (FM) were significantly higher in participants who consumed below the recommended level of protein intake as compared with other groups. Higher animal protein intake was associated with greater insulin secretion and lower triglycerides (TG). Total, low-density, and high-density cholesterol were significantly higher in participants who met the recommended protein intake as compared with the other groups. These data suggest that high protein consumption is associated with lower BMI, HC, WC, and FM, and can improve insulin resistance without affecting lipid profiles in this population. Furthermore, higher intake of animal protein can improve ß-cell function and lower plasma TG.


Asunto(s)
Composición Corporal , Constitución Corporal , Diabetes Mellitus Tipo 2/metabolismo , Proteínas en la Dieta/administración & dosificación , Ingestión de Alimentos/fisiología , Control Glucémico , Fenómenos Fisiológicos de la Nutrición/fisiología , Obesidad/metabolismo , Sobrepeso/metabolismo , Estado Prediabético/metabolismo , Ingesta Diaria Recomendada , Anciano , Femenino , Factores de Riesgo de Enfermedad Cardiaca , Humanos , Resistencia a la Insulina , Secreción de Insulina , Masculino , Persona de Mediana Edad , Triglicéridos/metabolismo
4.
Food Funct ; 11(1): 544-551, 2020 Jan 29.
Artículo en Inglés | MEDLINE | ID: mdl-31848551

RESUMEN

Hyperlipidemia associated with cardiovascular health, and bone loss with regard to osteoporosis contribute to increased morbidity and mortality and are influenced by diet. Soy protein has been shown to reduce cholesterol levels, and its isoflavones may improve bone health. The objective of this study was to determine the effects of soy protein on lipid profiles and biomarkers of bone metabolism and inflammation. Ninety men and women (aged 27-87) were randomly assigned to consume 40 g of soy or casein protein daily for three months. Both soy and casein consumption significantly reduced bone alkaline phosphatase (P = 0.011) and body fat % (P < 0.001), tended to decrease tartrate-resistant acid phosphatase (P = 0.066), and significantly increased serum insulin-like growth factor-I (IGF-1) (P < 0.001), yet soy increased IGF-1 to a greater extent (P = 0.01) than casein. Neither treatment affected total cholesterol, HDL cholesterol, LDL cholesterol, or C-reactive protein. These results demonstrate that daily supplementation of soy and casein protein may have positive effects on indices of bone metabolism and body composition, with soy protein being more effective at increasing IGF-1, an anabolic factor, which may be due to soy isoflavones' role in upregulating Runx2 gene expression, while having little effect on lipid profiles and markers of inflammation.


Asunto(s)
Huesos/metabolismo , HDL-Colesterol/metabolismo , LDL-Colesterol/metabolismo , Proteínas de Soja/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Composición Corporal , Densidad Ósea , Proteína C-Reactiva/metabolismo , Subunidad alfa 1 del Factor de Unión al Sitio Principal/genética , Subunidad alfa 1 del Factor de Unión al Sitio Principal/metabolismo , Femenino , Humanos , Factor I del Crecimiento Similar a la Insulina/genética , Factor I del Crecimiento Similar a la Insulina/metabolismo , Masculino , Persona de Mediana Edad , Adulto Joven
5.
Biosci Biotechnol Biochem ; 77(12): 2383-8, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24317051

RESUMEN

Tyrosinase exists in three forms in the catalytic cycle depending on the oxidation state of the copper: met- (Em), oxy- (E(ox)), and deoxy- (Ed). When O-quinones, products of the enzymatic reaction, evolve chemically to generate an O-diphenol in the reaction medium, the enzyme acts on a monophenol with O-diphenol as reductant, converting Em to Ed. The binding of Ed to molecular oxygen gives E(ox), which is active on monophenols, but when the O-quinone product does not generate O-diphenol through chemical evolution, the monophenol does not act as an enzyme substrate. The fact that E(ox) can be formed from Em with hydrogen peroxide can be used to help identify whether a monophenol is a substrate of tyrosinase. The results obtained in this study confirm that compounds previously described as inhibitors of the enzyme are true substrates of it.


Asunto(s)
Inhibidores Enzimáticos/metabolismo , Peróxido de Hidrógeno/metabolismo , Monofenol Monooxigenasa/metabolismo , Fenoles/metabolismo , Agaricales/enzimología , Hidroxilación , Monofenol Monooxigenasa/antagonistas & inhibidores , Oxidación-Reducción , Unión Proteica , Especificidad por Sustrato
6.
Biol Pharm Bull ; 36(7): 1140-5, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23811563

RESUMEN

We characterize umbelliferone, a derivative of 2,4-dihydroxycoumaric acid, as a substrate of polyphenol oxidase. This enzyme hydroxylates umbelliferone to esculetin, its o-diphenol, and then oxidizes it to o-quinone. The findings show that umbelliferone, an intermediate in one of the coumarin biosynthesis pathways, may be transformed into its o-diphenol, esculetin, which is also an intermediate in the same pathway. The activity of the enzyme on umbelliferone was followed by measuring the consumption of oxygen, spectrophotometrically and by HPLC. Kinetic constants characterizing the hydroxylation process were: kcat=0.09±0.02 s(-1) and Km=0.17±0.06 mM. The o-diphenol, esculetin, was a better substrate and when its oxidation was followed spectrophotometrically, the kinetic constants were: kcat=1.31±0.25 s(-1) and Km=0.035±0.002 mM. Both compounds therefore can be considered as alternative substrates to L-tyrosine and L-3,4-dihydroxyphenylalanine (L-DOPA), since both indirectly inhibit melanogenesis.


Asunto(s)
Catecol Oxidasa/química , Umbeliferonas/química , Agaricales/enzimología , Biocatálisis , Catecol Oxidasa/aislamiento & purificación , Cromatografía Líquida de Alta Presión , Hidroxilación , Cinética , Estructura Molecular , Espectrofotometría , Especificidad por Sustrato
7.
Biosci Biotechnol Biochem ; 74(9): 1777-87, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20834177

RESUMEN

The effect of NADH on melanogenesis under aerobic conditions involves three types of reaction: (a) acting as tyrosinase substrate (a competitive substrate of L-tyrosine and L-DOPA), (b) irreversible inactivation acting as a suicide substrate of tyrosinase, and (c) non-enzymatic reduction of o-dopaquinone by NADH. Under anaerobic conditions, NADH irreversibly inhibits the enzymatic forms met-tyrosinase and deoxy-tyrosinase. In this paper, we kinetically characterize this coenzyme as it acts as a tyrosinase suicide substrate and propose a kinetic mechanism to explain its oxidation by tyrosinase. In addition, the compound is characterized as an irreversible inhibitor of met-tyrosinase and deoxy-tyrosinase.


Asunto(s)
Indoles/antagonistas & inhibidores , Monofenol Monooxigenasa/metabolismo , NAD/farmacología , Agaricales/química , Agaricales/fisiología , Benzoquinonas , Dihidroxifenilalanina/análogos & derivados , Proteínas Fúngicas , Indoles/metabolismo , Cinética , Melaninas/metabolismo , Monofenol Monooxigenasa/química , Oxidación-Reducción , Especificidad por Sustrato
8.
Biosci Biotechnol Biochem ; 74(5): 1108-9, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20460701

RESUMEN

Tetrahydrobiopterine (6BH(4)) can diminish the oxidative stress undergone by keratinocytes and melanocytes by reducing the o-quinones generated by the oxidation of the corresponding o-diphenols. We found that 6BH(4) and their analogs reduced all the o-quinones studied. The formal potentials of different quinone/diphenol pairs indicate that the o-quinones with withdrawing groups are more potent oxidants than those with donating groups.


Asunto(s)
Benzoquinonas/metabolismo , Biocatálisis , Monofenol Monooxigenasa/metabolismo , Pterinas/farmacología , Biopterinas/química , Biopterinas/farmacología , Oxidación-Reducción , Pterinas/química
9.
Biosci Biotechnol Biochem ; 73(6): 1308-13, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19502746

RESUMEN

Carbidopa and benserazide have been described as inhibitors of dopa decarboxylase and both have been used in the treatment of Parkinson's disease. Because of their chemical structure as polyphenols, these compounds can behave as substrates of tyrosinase and peroxidase. We demonstrate that these enzymes oxidize both substrates. Since o-quinones are unstable, a chronometric method for enzymatic initial rate determinations was used based on measurements of the lag period in the presence of micromolar concentrations of ascorbic acid to kinetically characterize these substrates. In the case of tyrosinase, the values of the Michaelis constant for both substrates were greater than those described for dopa, although the catalytic constants were lower, probably due to the greater size of the substitute group in carbon 1. As regards peroxidase, the saturation of the enzyme by both substrates is possible, however this effect does not occur with the isomers of dopa. The distance of the charges from the benzene ring may enable the ring to approach the iron of the active site and, therefore, act.


Asunto(s)
Benserazida/metabolismo , Carbidopa/metabolismo , Monofenol Monooxigenasa/metabolismo , Peroxidasas/metabolismo , Cinética , Oxidación-Reducción , Espectrofotometría Ultravioleta
10.
Biosci Biotechnol Biochem ; 71(2): 390-6, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17284853

RESUMEN

Esculetin has been described as an inhibitor of tyrosinase and polyphenol oxidase and, therefore, of melanogenesis. In this work, we demonstrate that esculetin is not an inhibitor but a substrate of mushroom polyphenol oxidase (PPO) and horseradish peroxidase (POD), enzymes which oxidize esculetin, generating its o-quinone. Since o-quinones are very unstable, the usual way of determining the enzymatic activity (slope of recordings) is difficult. For this reason, we developed a chronometric method to characterize the kinetics of this substrate, based on measurements of the lag period in the presence of micromolar concentrations of ascorbic acid. The catalytic constant determined was of the same order for both enzymes. However, polyphenol oxidase showed greater affinity (a lower Michaelis constant) than peroxidase for esculetin. The affinity of PPO and POD towards oxygen and hydrogen peroxide was very high, suggesting the possible catalysis of both enzymes in the presence of low physiological concentrations of these oxidizing substrates. Taking into consideration optimum pHs of 4.5 and 7 for POD and PPO respectively, and the acidic pHs of melanosomes, the studies were carried out at pH 4.5 and 7. The in vivo pH might be responsible for the stronger effect of these enzymes on L-tyrosine and L-3,4-dihydroxyphenylanaline (L-DOPA) (towards melanogenesis) and on cumarins such as esculetin towards an alternative oxidative pathway.


Asunto(s)
Catecol Oxidasa/química , Glicósidos/química , Peroxidasa/química , Pregnenolona/análogos & derivados , Agaricales/enzimología , Ácido Ascórbico/metabolismo , Peroxidasa de Rábano Silvestre/química , Indicadores y Reactivos , Cinética , Monofenol Monooxigenasa/química , Oxidación-Reducción , Ácido Peryódico/metabolismo , Pregnenolona/química , Quinonas/química , Quinonas/metabolismo , Espectrofotometría Ultravioleta , Vitaminas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...